Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCOT: 12 vs 24 weeks of adjuvant chemotherapy in colorectal cancer
NCT00749450Phase 3Completed
- Sponsor
- Cancer Research UK
- Start
- Mar 2008
- Primary completion
- Nov 2017
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of oxaliplatin, fluorouracil, capecitabine in colorectal cancer (CRC), sponsored by Cancer Research UK. Started Mar 2008; status: completed.
02
Drugs
oxaliplatinfluorouracilcapecitabine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00749450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00749450.